Mosquito-borne disease surveillance report: September 8 to 14, 2019 (Week 37)

Table 1. Year-to-date (YTD) WNV human cases, by disease classification and province (January 1 - September 14, 2019)

Province	Clinical cases			Total of clinical cases Footnote 1	Asymptomatic infections Footnote 2	YTD grand total	Rate (per 100,000) Footnote 3
	Neurological	Non-neurological	Unclassified
British Columbia	0	1	0	1	0	1	0.02
Alberta	0	0	0	0	0	0	0.00
Saskatchewan	0	-	-	0	0	0	0.00
Manitoba	0	0	0	0	0	0	0.00
Ontario	0	2	1	3	1	4	0.03
Quebec	0	1	0	1	0	1	0.01
Maritime provinces	0	0	0	0	0	0	0.00
Territories	0	0	0	0	0	0	0.00
Total	0	4	1	5	1	6	0.02
Footnote 1 Clinical cases are the sum of confirmed and probable: WNV neurological and non-neurological syndromes, along with any unclassified. Return to footnote 1 referrer Footnote 2 Satisfies WNV diagnostic test criteria in the absence of clinical criteria (i.e., asymptomatic blood donors whose blood is screened by blood operators, Canadian Blood Services or Héma-Québec. Return to footnote 2 referrer Footnote 3 Calculated with grand total of clinical and asymptomatic cases, using Statistics Canada 2018 population estimates. Return to footnote 3 referrer

Figure 1 - Text equivalent

Since the start of the transmission season, 5 human cases of WNV have been reported to PHAC.

Mosquito, wild bird and equine epidemiology

As of week 37, PHAC has been notified of 10,144 mosquito pools tested for WNV. Of these, 83 (0.82%) were positive in Quebec (10), Ontario (55) and Manitoba (6) (Table 2).

Twenty-four of 53 dead wild birds have tested positive for WNV, by the Canadian Wildlife Health Cooperative (CWHC) in Saskatchewan (1), Ontario (17) and Quebec (6) (Table 3).

Since the start of this season, the Canadian Food Inspection Agency (CFIA) has reported 5 horses that tested positive for WNV in British Columbia (1), Saskatchewan (1), Alberta (1), Ontario (1) and Quebec (1) (Table 3).

Figure 2 - Text equivalent

Since the start of the transmission season, 5 human cases of West Nile virus have been reported to PHAC. A total of 24 birds and 0.82% of mosquito pools have tested positive for WNV in Canada and reported to PHAC.

Table 2. Year-to-date WNV positive pools and percent positive by province and nationally (January 1 - September 14, 2019)

Province Footnote 1	Positive pools	Total pools tested	Percent positive
Saskatchewan	0	200	0.00 %
Manitoba	6	1,166	0.51 %
Ontario	65	7,335	0.89 %
Québec	12	1,433	0.83 %
Total	83	10,144	0.82 %
Footnote 1 Mosquito surveillance data is reported by the following 4 provinces: Saskatchewan, Manitoba Ontario and Quebec. Return to footnote 1 referrer

Table 3. Number of WNV positive animal cases for current week and year to date (January 1 - September 14, 2019)

Province	Wild birds Footnote 1		Equine
	Week 37	Year-to-date total	Week 37	Year-to-date total
British Columbia	0	0	0	1
Alberta	0	0	0	1
Saskatchewan	0	1	0	1
Manitoba	0	0	0	0
Ontario	0	17	1	1
Quebec	1	6	0	1
Maritime provinces	0	0	0	0
Territories	0	0	0	0
Total	1	24	1	5
Footnote 1 Not all provinces conduct dead wild bird surveillance as part of their respective WNV surveillance program. However, WNV positive dead wild birds may be identified through the National Wildlife Disease Surveillance Program, CWHC or by specific provinces. Return to footnote 1 referrer

California serogroup

As of September 14, 2019, no human exposures or cases of California serogroup virus have been reported by the National Microbiology Laboratory.

Eastern equine encephalitis

The CFIA has reported 6 horses that tested positive for eastern equine encephalitis virus (EEEV) in Ontario.

No human cases of EEEV have been reported to PHAC since the beginning of the 2019 transmission season.

Provincial/territorial and international surveillance links

Data reported to PHAC is subject to change and may differ from provincial webpages due to reporting timelines. To obtain the latest arbovirus surveillance data, please refer to the following jurisdictional/regional webpages:

Notes

Thank you to all our partners for participating in the National WNV/MBD surveillance program.